Akash Pal, Ph.D.
Asmaa Elshikha, Ph.D.
Emily Wright, Ph.D.
Stress effects on serotonin system, In-vivo neuropeptide imaging, Behavioral neuroscience
Lucas Solano, Ph.D.
Development of small molecule degraders and nanosystems to enhance cancer therapeutic options
Luodon Yu, Ph.D.
Marwa Zafarullah, Ph.D.
Human genetics and genomics, Biomarker development for neurodegenerative disorders
Rochelin Dalangin, Ph.D.
Protein engineering of biosensors, fluorescence imaging
Shuwen Zhang, Ph.D.
Bioinformatics, Genetics and genomics, Developmental Biology
Sohaib Mahri, Ph.D.
Developing a new nanomedicine platform capable of delivering drugs of different biological/chemical natures to treat cancers and other diseases.
Subbroto Saha, Ph.D.
Developmental biology, birth defects including Craniofacial abnormalities and Neural tube defect, Molecular oncology
Xiaolong Zeng, Ph.D.
Xingling Zheng, Ph.D.
Understanding of molecular mechanisms underlying prostate cancer progression. Development of new biomarker.
Xiong Zhang, Ph.D.
Nuclear receptor in Prostate cancer; anti-tumor drug discovery
Yangxiong Li, Ph.D.
Yanyu Huang, Ph.D.
Ya-Ping (Alvina) Shiau, Ph.D.
Immunotoxicology and immunopharmacology. Cancer immunotherapy. Cells crosstalk between tumor and immune cells.